SEC Form 4 · accession 0002062781-26-000016

Hinge Health, Inc. · HNGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Gabriel M.I. Mecklenburg

Director · Other

Period of report

Jul 1, 2026

Accepted (ET)

Jul 2, 2026 · 4:35 pm EDT

Rule 10b5-1 plan

yes — trade under a plan

Issuer CIK

0001673743

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jul 1, 2026	C	83,334	$0.00	A	83,334	D
Class A Common Stock^F2	Jul 1, 2026	S	3,500	$82.968	D	79,834	D
Class A Common Stock^F3	Jul 1, 2026	S	3,900	$83.9454	D	75,934	D
Class A Common Stock^F4	Jul 1, 2026	S	56,518	$85.0031	D	19,416	D
Class A Common Stock^F5	Jul 1, 2026	S	18,675	$85.7535	D	741	D
Class A Common Stock^F6	Jul 1, 2026	S	741	$86.5078	D	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F8,F7	—	Jul 1, 2026	C	83,334	D	—	—	Class A Common Stock	83,334	1,644,007	D
Class B Common Stock^F7	—	holding	—	—	—	—	—	Class A Common Stock	857,880	857,880	I
Class B Common Stock^F7	—	holding	—	—	—	—	—	Class A Common Stock	383,592	383,592	I

Explanation of responses

F1The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
F2Represents the weighted average sale price. The lowest price at which shares were sold was $82.38 and the highest price at which shares were sold was $83.29. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F3Represents the weighted average sale price. The lowest price at which shares were sold was $83.40 and the highest price at which shares were sold was $84.33. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F4Represents the weighted average sale price. The lowest price at which shares were sold was $84.40 and the highest price at which shares were sold was $85.39. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F5Represents the weighted average sale price. The lowest price at which shares were sold was $85.40 and the highest price at which shares were sold was $86.38. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F6Represents the weighted average sale price. The lowest price at which shares were sold was $86.42 and the highest price at which shares were sold was $86.58. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F7Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
F8Excludes 944,250 performance stock units held by the Reporting Person.